Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer
Cancer Letters · 2026-04 · 644 · 218328
DOI: 10.1016/j.canlet.2026.218328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-04. Verfasst von Zewei Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianji…. Hauptthemen laut MEDLINE: Breast Neoplasms, Adaptor Proteins, Signal Transducing, Cell Cycle Proteins, L-Lactate Dehydrogenase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic-epigenetic crosstalk accelerates breast cancer (BC) progression; however, the conduit linking glycolytic flux to chromatin remodeling remains incompletely defined. Here, we delineate a kinase-metabolism-epigenetic axis centered on the Mitogen-Activated Protein Kinase Associated Protein 1 (MAPKAP1, also known as SIN1). Single-cell transcriptomic profiling of highly invasive tumors identifies SIN1 as a central node co-enriched with epithelial-mesenchymal transition and proliferation programs. Biochemical mapping and mass spectrometry demonstrate that SIN1 scaffolds TTK to promote phosphorylation of lactate dehydrogenase A (LDHA) at Tyr239 (p-LDHA^239), thereby amplifying glycolysis and lactate production. The resulting lactate accumulation increases histone H3K18 lactylation (H3K18la), which, as shown by ChIP-seq, is enriched at the Solute Carrier Family 2 Member 3 (SLC2A3, also known as GLUT3) promoter, upregulating GLUT3 and enhancing glucose uptake, thus establishing a self-reinforcing SIN1/TTK/LDHA-H3K18la-GLUT3 feed-forward loop. Structure-function analyses using domain truncations, molecular docking, and high-throughput virtual screening nominate LR-90 as a small-molecule inhibitor of the SIN1/TTK/LDHA complex. LR-90 reduces p-LDHA^239, lactate levels, H3K18la occupancy at the GLUT3 promoter, glucose uptake, invasion, and tumor growth, and it synergizes with standard chemotherapy in patient-derived organoids and mouse xenografts. Clinically, elevated SIN1 expression is associated with adverse pathological features and inferior overall survival. Collectively, these findings link SIN1-mediated recruitment of TTK for LDHA phosphorylation to histone lactylation and GLUT3-driven metabolic reprogramming, and suggest that pharmacological disruption of this axis with LR-90, alone or in combination with standard chemotherapy, may offer a therapeutic strategy for high-glycolytic, high-lactate breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China; Key Laboratory of Cancer Prevention and Therapy, Tia…
- Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China; Pancreas Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, State Key Laboratory of Dru…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, Z., Jia, W., Li, Z., Shi, S., Zhou, J., Ning, C., Yu, Z., Liu, X., Cao, X., Zheng, H., Wang, X., Wang, X., & Yu, Y. (2026). Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer. Cancer Letters, 644, 218328. https://doi.org/10.1016/j.canlet.2026.218328
Vancouver
Zhao Z, Jia W, Li Z, Shi S, Zhou J, Ning C, et al. Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer. Cancer Letters. 2026;644:218328. doi:10.1016/j.canlet.2026.218328
BibTeX
@article{Zhao2026,
author = {Zhao, Zewei and Jia, Wenbin and Li, Zekun and Shi, Shangheng and Zhou, Jiaqi and Ning, Chunlan and Yu, Zhihao and Liu, Xiaofeng and Cao, Xuchen and Zheng, Hong and Wang, Xin and Wang, Xiuchao and Yu, Yue},
title = {Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer},
journal = {Cancer Letters},
year = {2026},
volume = {644},
pages = {218328},
doi = {10.1016/j.canlet.2026.218328}
}
EUVIMED